EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Gp130–HIF1α axis–induced vascular damage is prevented by the short-term inhibition of IL-6 receptor signaling

Sujin Kang iD, Shinya Onishi, Zhenzhen Ling, Hitomi Inoue, Yingying Zhang, Hao Chang, Hui Zhao, Tong Wang, Daisuke Okuzaki iD, Hiroshi Matsuura iD, Hyota Takamatsu, Jun Oda und 1 weitere

Proceedings of the National Academy of Sciences · 2024

DOI: 10.1073/pnas.2315898120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Sujin Kang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immune Regulation, Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, Japan. Hauptthemen laut MEDLINE: Cytokine Receptor gp130, Interleukin-6, Receptors, Interleukin-6, Sepsis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MEXT | Japan Society for the Promotion of Science (JSPS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protection against endothelial damage is recognized as a frontline approach to preventing the progression of cytokine release syndrome (CRS). Accumulating evidence has demonstrated that interleukin-6 (IL-6) promotes vascular endothelial damage during CRS, although the molecular mechanisms remain to be fully elucidated. Targeting IL-6 receptor signaling delays CRS progression; however, current options are limited by persistent inhibition of the immune system. Here, we show that endothelial IL-6 trans-signaling promoted vascular damage and inflammatory responses via hypoxia-inducible factor-1α (HIF1α)–induced glycolysis. Using pharmacological inhibitors targeting HIF1α activity or mice with the genetic ablation of gp130 in the endothelium, we found that inhibition of IL-6R (IL-6 receptor)–HIF1α signaling in endothelial cells protected against vascular injury caused by septic damage and provided survival benefit in a mouse model of sepsis. In addition, we developed a short half-life anti-IL-6R antibody (silent anti-IL-6R antibody) and found that it was highly effective at augmenting survival for sepsis and severe burn by strengthening the endothelial glycocalyx and reducing cytokine storm, and vascular leakage. Together, our data advance the role of endothelial IL-6 trans-signaling in the progression of CRS and indicate a potential therapeutic approach for burns and sepsis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytokine Receptor gp130Interleukin-6Receptors, Interleukin-6SepsisHypoxia-Inducible Factor 1, alpha SubunitAnimalsMiceCytokine Release SyndromeEndothelial Cells

Stichwörter der Autor:innen

IL-6anti-IL-6 receptor antibodyburn injurycytokine release syndromeendothelial cell

Substanzen

Cytokine Receptor gp130Interleukin-6Receptors, Interleukin-6Hif1a protein, mouseIl6ra protein, mouseIl6st protein, mouseHypoxia-Inducible Factor 1, alpha Subunit

Autor:innen und Institutionen

  • Department of Immune Regulation, Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, Japan.
  • Department of Immune Regulation, Center for Infectious Disease Education and Research, Osaka University, Suita, Osaka 565-0871, Japan.
  • Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan.
  • Next Generation-Sequencing Core Facility, Bioinformatics Center, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan.
  • Department of Clinical Research Center for Autoimmune Disease, Osaka Minami Medical Center, National Hospital Organization, Kawachinagano, Osaka 586-8521, Japan.
  • Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.

ORCID-Profile: Sujin Kang, Daisuke Okuzaki, Hiroshi Matsuura

Förderung

  • MEXT | Japan Society for the Promotion of Science (JSPS)

Zitieren

APA

Kang, S., Onishi, S., Ling, Z., Inoue, H., Zhang, Y., Chang, H., Zhao, H., Wang, T., Okuzaki, D., Matsuura, H., Takamatsu, H., Oda, J., & Kishimoto, T. (2024). Gp130–HIF1α axis–induced vascular damage is prevented by the short-term inhibition of IL-6 receptor signaling. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2315898120

Vancouver

Kang S, Onishi S, Ling Z, Inoue H, Zhang Y, Chang H, et al. Gp130–HIF1α axis–induced vascular damage is prevented by the short-term inhibition of IL-6 receptor signaling. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2315898120

BibTeX
@article{Kang2024,
  author = {Kang, Sujin and Onishi, Shinya and Ling, Zhenzhen and Inoue, Hitomi and Zhang, Yingying and Chang, Hao and Zhao, Hui and Wang, Tong and Okuzaki, Daisuke and Matsuura, Hiroshi and Takamatsu, Hyota and Oda, Jun and Kishimoto, Tadamitsu},
  title = {Gp130–HIF1α axis–induced vascular damage is prevented by the short-term inhibition of IL-6 receptor signaling},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  doi = {10.1073/pnas.2315898120}
}
Kostenlos starten →